Holen Sie sich die Stockscreener-App
40.88
2.20%
-0.92
Schlusskurs vom Vortag:
$41.80
Offen:
$40.74
24-Stunden-Volumen:
116.45K
Relative Volume:
0.16
Marktkapitalisierung:
$1.46B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-9.72%
1M Leistung:
-9.82%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$40.62
$42.79
1-Wochen-Bereich:
$39.20
$45.56
52-Wochen-Spanne:
$14.72
$49.91
First Tracks Biotherapeutics Inc Stock (TRAX) Company Profile
Firmenname
First Tracks Biotherapeutics Inc
Sektor
Branche
Telefon
212-373-3000
Adresse
10770 WATERIDGE CIRCLE, SAN DIEGO
Compare TRAX vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRAX
First Tracks Biotherapeutics Inc
|
40.91 | 1.49B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
521.27 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.01 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,004.37 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.42 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.19 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
First Tracks Biotherapeutics Inc Stock (TRAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-24 | Eingeleitet | Leerink Partners | Outperform |
| 2026-04-24 | Eingeleitet | Wedbush | Outperform |
| 2026-04-23 | Eingeleitet | JP Morgan | Overweight |
| 2026-04-22 | Eingeleitet | Barclays | Overweight |
| 2026-04-21 | Eingeleitet | UBS | Buy |
First Tracks Biotherapeutics Inc Aktie (TRAX) Neueste Nachrichten
TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart | MEXC - mexc.co
First Tracks Biotherapeutics Director Sold Shares Worth Over $1.7M - TradingView
First Tracks Biotherapeutics (TRAX) director sells shares after option exercise - Stock Titan
H.C. Wainwright Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $57 - Moomoo
TRAX Reiterates by First Tracks -- Price Target Maintained at $5 - GuruFocus
Long term debt to total assets ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Which stocks are gapping on Wednesday? - ChartMill
Cash flow from operating activities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
EBIT per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total debt of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
After tax other income/expense of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics Announces Participation in September Investor Conferences - finance.yahoo.com
Non-controlling/minority interest of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total liabilities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Taxes of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Diluted shares outstanding of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
Total operating expenses of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Diluted earnings per share (diluted EPS) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics, Inc. Revenue Breakdown – NASDAQ:TRAX - TradingView
Total revenue of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
Dilution adjustment of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Price to cash flow ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
CapEx per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Number of shareholders of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Enterprise value to EBITDA forward of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
Net debt of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Gross profit of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
EBIT of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Net current asset value per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Free cash flow of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total liabilities & shareholders' equities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Enterprise value to EBITDA ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
EBITDA per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Enterprise value to EBIT forward of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Operating expenses (excl. COGS) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Diluted net income available to common stockholders of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
AnaptysBio, Inc. (ANAB) Earnings Preview: The First Full Royalty-Model Quarter Matters More Than the Headline EPS - AlphaStreet
J.P. Morgan Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $65 - Moomoo
Piper Sandler Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $95 - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
First Tracks Biotherapeutics CBO Benjamin Stone Receives 60,492 Performance Stock Units - Kalkine Media
First Tracks Biotherapeutics' CMO Paul F. Lizzul Earns 60,492 Performance Stock Units Following Certified Milestones - Kalkine Media
First Tracks Biotherapeutics CEO Daniel Faga Awarded 193,575 Performance Stock Units - Kalkine Media
First Tracks (TRAX) insider records new share trades - Stock Titan
First Tracks Biotherapeutics (TRAX) insider updates holdings - Stock Titan
First Tracks Biotherapeutics (TRAX) insider logs trades - Stock Titan
FIRST TRACKS BIOTHERAPEUTICS INC : JP MORGAN RAISES TARGET PRICE TO $65 FROM $30 - Moomoo
Wolfe Research Begins Coverage on First Tracks Biotherapeutics (NASDAQ:TRAX) - MarketBeat
Wolfe Research initiates First Tracks stock with outperform rating By Investing.com - Investing.com Canada
We're Hopeful That First Tracks Biotherapeutics (NASDAQ:TRAX) Will Use Its Cash Wisely - Sahm
Why Did CRCL Stock Lose Steam? Wall Street Split On Circle’s Banking Win - Stocktwits
Finanzdaten der First Tracks Biotherapeutics Inc-Aktie (TRAX)
Es liegen keine Finanzdaten für First Tracks Biotherapeutics Inc (TRAX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
First Tracks Biotherapeutics Inc-Aktie (TRAX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ware J. Anthony | Director |
Sep 02 '26 |
Sale |
44.78 |
39,265 |
1,758,145 |
15,660 |
0.69%
3.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):